Quote | Douglas Elliman Inc. (NYSE:DOUG)
Last: | $1.40 |
---|---|
Change Percent: | -1.57% |
Open: | $1.29 |
Close: | $1.40 |
High: | $1.415 |
Low: | $1.29 |
Volume: | 1,881,684 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Douglas Elliman Inc. (NYSE:DOUG)
2024-07-02 08:55:02 ET More on Douglas Elliman Douglas Elliman Inc. (DOUG) Q1 2024 Earnings Call Transcript Douglas Elliman: Settling Class Action Lawsuits A Positive, But Housing Remains Unaffordable Douglas Elliman to pay $7.75M to settle broker commission lawsuits...
Strengthens balance sheet and fuels long-term strategic growth and expansion plans Announces preliminary second quarter gross transaction value in the range of $10.25 billion to $11.25 billion and strong cash position Douglas Elliman Inc. (NYSE:DOUG) today announced the closing ...
Message Board Posts | Douglas Elliman Inc. (NYSE:DOUG)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Strengthens balance sheet and fuels long-term strategic growth and expansion plans Announces preliminary second quarter gross transaction value in the range of $10.25 billion to $11.25 billion and strong cash position Douglas Elliman Inc. (NYSE:DOUG) today announced the closing ...
First Quarter 2024 Highlights: Consolidated revenues of $200.2 million compared to $214.0 million in the prior year quarter Douglas Elliman’s real estate brokerage segment reported gross transaction value of approximately $7.1 billion, compared to approximately $7.3 billion...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...